Inositol role in polycystic ovary syndrome (PCOS) and the awareness of Iraqi doctors regarding this role

Haidar A Abdulamir

Makale detayları

Inositol role in polycystic ovary syndrome (PCOS) and the awareness of Iraqi doctors regarding this role

Yazarlar:

Haidar A Abdulamir

Yayıncı:

Marmara University

Ana Başlıklar:

Pharmacognosy

Dergi:

Journal of Research in Pharmacy Vol.29 Issue 5, pp.1972-1977

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001342422

pISSN:

2630-6344

Anahtar kelimeler:

Özet:

 Polycystic ovary syndrome PCOS is a common endocrine disorder affecting females of reproductive age. The study aimed to evaluate the level of knowledge and awareness among Iraqi doctors regarding the potential role of inositol as a treatment for polycystic ovary syndrome PCOS, in a questionnaire-based study that include 14 specialists in Al-Ameerat Hospital and Al-Bilad Hospital, and 11 board students in the Medical City in Baghdad-Iraq in the duration between November 2022 to April 2023 which revealed that 23 of them 92 were aware and 20 of them 80 prescribed inositol for PCOS and 13 of subjects 52 have reported a response rate of 51-75 toward inositol treatment while 9 participant 36 reported 26-50 and 3 doctors 36  reported a rate of 0-25. Nine participants 36 think that the major cause that limits inositol use is the lack of enough studies while 8 participant 32 have thought that the price is the cause, whereas seven participant 28 have thought that the undetectable effect of inositol is the cause. Majority of participants 64 prescribed the normal dose of inositol whereas four participants 16 have prescribed dose lower than the normal dose firstly that become increased according to the patients response and tolerance. It was concluded that majority of the Iraqi doctors were aware of the importance and the significance role of Inositol, and they were prescribing it to their patients who showed a high rate of response but participants also thought that there are many reasons that limit inositol usage widely for PCOS, that include mainly the lack of supporting evidence and the price.

 Polycystic ovary syndrome PCOS is a common endocrine disorder affecting females of reproductive age. The study aimed to evaluate the level of knowledge and awareness among Iraqi doctors regarding the potential role of inositol as a treatment for polycystic ovary syndrome PCOS, in a questionnaire-based study that include 14 specialists in Al-Ameerat Hospital and Al-Bilad Hospital, and 11 board students in the Medical City in Baghdad-Iraq in the duration between November 2022 to April 2023 which revealed that 23 of them 92 were aware and 20 of them 80 prescribed inositol for PCOS and 13 of subjects 52 have reported a response rate of 51-75 toward inositol treatment while 9 participant 36 reported 26-50 and 3 doctors 36  reported a rate of 0-25. Nine participants 36 think that the major cause that limits inositol use is the lack of enough studies while 8 participant 32 have thought that the price is the cause, whereas seven participant 28 have thought that the undetectable effect of inositol is the cause. Majority of participants 64 prescribed the normal dose of inositol whereas four participants 16 have prescribed dose lower than the normal dose firstly that become increased according to the patients response and tolerance. It was concluded that majority of the Iraqi doctors were aware of the importance and the significance role of Inositol, and they were prescribing it to their patients who showed a high rate of response but participants also thought that there are many reasons that limit inositol usage widely for PCOS, that include mainly the lack of supporting evidence and the price.

 Polycystic ovary syndrome PCOS is a common endocrine disorder affecting females of reproductive age. The study aimed to evaluate the level of knowledge and awareness among Iraqi doctors regarding the potential role of inositol as a treatment for polycystic ovary syndrome PCOS, in a questionnaire-based study that include 14 specialists in Al-Ameerat Hospital and Al-Bilad Hospital, and 11 board students in the Medical City in Baghdad-Iraq in the duration between November 2022 to April 2023 which revealed that 23 of them 92 were aware and 20 of them 80 prescribed inositol for PCOS and 13 of subjects 52 have reported a response rate of 51-75 toward inositol treatment while 9 participant 36 reported 26-50 and 3 doctors 36  reported a rate of 0-25. Nine participants 36 think that the major cause that limits inositol use is the lack of enough studies while 8 participant 32 have thought that the price is the cause, whereas seven participant 28 have thought that the undetectable effect of inositol is the cause. Majority of participants 64 prescribed the normal dose of inositol whereas four participants 16 have prescribed dose lower than the normal dose firstly that become increased according to the patients response and tolerance. It was concluded that majority of the Iraqi doctors were aware of the importance and the significance role of Inositol, and they were prescribing it to their patients who showed a high rate of response but participants also thought that there are many reasons that limit inositol usage widely for PCOS, that include mainly the lack of supporting evidence and the price.

 Polycystic ovary syndrome PCOS is a common endocrine disorder affecting females of reproductive age. The study aimed to evaluate the level of knowledge and awareness among Iraqi doctors regarding the potential role of inositol as a treatment for polycystic ovary syndrome PCOS, in a questionnaire-based study that include 14 specialists in Al-Ameerat Hospital and Al-Bilad Hospital, and 11 board students in the Medical City in Baghdad-Iraq in the duration between November 2022 to April 2023 which revealed that 23 of them 92 were aware and 20 of them 80 prescribed inositol for PCOS and 13 of subjects 52 have reported a response rate of 51-75 toward inositol treatment while 9 participant 36 reported 26-50 and 3 doctors 36  reported a rate of 0-25. Nine participants 36 think that the major cause that limits inositol use is the lack of enough studies while 8 participant 32 have thought that the price is the cause, whereas seven participant 28 have thought that the undetectable effect of inositol is the cause. Majority of participants 64 prescribed the normal dose of inositol whereas four participants 16 have prescribed dose lower than the normal dose firstly that become increased according to the patients response and tolerance. It was concluded that majority of the Iraqi doctors were aware of the importance and the significance role of Inositol, and they were prescribing it to their patients who showed a high rate of response but participants also thought that there are many reasons that limit inositol usage widely for PCOS, that include mainly the lack of supporting evidence and the price.

Makale detayları

Inositol role in polycystic ovary syndrome (PCOS) and the awareness of Iraqi doctors regarding this role

Yazarlar:

Haidar A Abdulamir

Yayıncı:

Marmara University

Ana Başlıklar:

Pharmacognosy

Dergi:

Journal of Research in Pharmacy Vol.29 Issue 5, pp.1972-1977

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001342422

pISSN:

2630-6344

Hyperandrogenism

inositol

insulin resistance

menstrual irregularities

polycystic ovary syndrome

Sayı

Makale detayları

Inositol role in polycystic ovary syndrome (PCOS) and the awareness of Iraqi doctors regarding this role

Yazarlar: Haidar A Abdulamir

Yayıncı: Marmara University

Ana Başlıklar: Pharmacognosy

Dergi: Journal of Research in Pharmacy Vol.29 Issue 5, pp.1972-1977

Belge Tipi: Makale

Yayın Tarihi: 1/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001342422

pISSN: 2630-6344

Hyperandrogenism

inositol

insulin resistance

menstrual irregularities

polycystic ovary syndrome

Sayı

Yazarlar:

Haidar A Abdulamir

Yayıncı:

Marmara University

Ana Başlıklar:

Pharmacognosy

Dergi:

Journal of Research in Pharmacy Vol.29 Issue 5, pp.1972-1977

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001342422

pISSN:

2630-6344